Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke F Peterson

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|February 9, 2011
Chronic myeloid leukemia stem cells and developing therapiesNicholas J Donato, Luke F Peterson
Critical Reviews in Eukaryotic Gene Expression|April 16, 2013
Combined gene expression and DNA occupancy profiling as a strategy to identify therapeutic target(s) in t(8;21) acute myeloid leukemiaMiao-Chia Lo, Luke F Peterson
Oncogene|May 25, 2004
The 8;21 translocation in leukemogenesisLuke F Peterson, Dong-Er Zhang
Blood|February 8, 2007
The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETOLuke F Peterson, Ming Yan, Dong-Er Zhang
Oncotarget|October 25, 2019
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cellsHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Blood Cells, Molecules & Diseases|August 19, 2007
Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesisLuke F Peterson, Miao-Chia Lo, Akiko Joo Okumura, et al.
Experimental Hematology|May 30, 2007
Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cellsAkiko Joo Okumura, Luke F Peterson, Miao-Chia Lo, et al.
Blood|May 31, 2008
t(8;21)(q22;q22) Fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expressionAkiko J Okumura, Luke F Peterson, Fumihiko Okumura, et al.
Oncotarget|February 22, 2021
Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanomaHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Haematologica|October 15, 2020
SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformationJames Ropa, Nirmalya Saha, Hsiangyu Hu, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|February 9, 2011
Chronic myeloid leukemia stem cells and developing therapiesNicholas J Donato, Luke F Peterson
Critical Reviews in Eukaryotic Gene Expression|April 16, 2013
Combined gene expression and DNA occupancy profiling as a strategy to identify therapeutic target(s) in t(8;21) acute myeloid leukemiaMiao-Chia Lo, Luke F Peterson
Oncogene|May 25, 2004
The 8;21 translocation in leukemogenesisLuke F Peterson, Dong-Er Zhang
Blood|February 8, 2007
The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETOLuke F Peterson, Ming Yan, Dong-Er Zhang
Oncotarget|October 25, 2019
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cellsHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Blood Cells, Molecules & Diseases|August 19, 2007
Inability of RUNX1/AML1 to breach AML1-ETO block of embryonic stem cell definitive hematopoiesisLuke F Peterson, Miao-Chia Lo, Akiko Joo Okumura, et al.
Experimental Hematology|May 30, 2007
Expression of AML/Runx and ETO/MTG family members during hematopoietic differentiation of embryonic stem cellsAkiko Joo Okumura, Luke F Peterson, Miao-Chia Lo, et al.
Blood|May 31, 2008
t(8;21)(q22;q22) Fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expressionAkiko J Okumura, Luke F Peterson, Fumihiko Okumura, et al.
Oncotarget|February 22, 2021
Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanomaHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Haematologica|October 15, 2020
SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformationJames Ropa, Nirmalya Saha, Hsiangyu Hu, et al.
Pageof 4